Registered number
08639222
RSR Pharmacare Limited
Unaudited Filleted Accounts
31 August 2024
RSR Pharmacare Limited
Registered number: 08639222
Balance Sheet
as at 31 August 2024
Notes 2024 2023
£ £
Fixed assets
Investments 3 3,917,723 3,917,723
Current assets
Debtors 4 135,956 2,376
Cash at bank and in hand 229,489 608,240
365,445 610,616
Creditors: amounts falling due within one year 5 (268,904) (367,483)
Net current assets 96,541 243,133
Total assets less current liabilities 4,014,264 4,160,856
Creditors: amounts falling due after more than one year 6 (780,217) (860,194)
Net assets 3,234,047 3,300,662
Capital and reserves
Called up share capital 200 200
Share premium 299,900 299,900
Profit and loss account 2,933,947 3,000,562
Shareholders' funds 3,234,047 3,300,662
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr. H. Panchmatia
Director
Approved by the board on 9 May 2025
RSR Pharmacare Limited
Notes to the Accounts
for the year ended 31 August 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 0 0
3 Investments
Other
investments
£
Cost
At 1 September 2023 3,917,723
At 31 August 2024 3,917,723
4 Debtors 2024 2023
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 15,956 -
Other debtors 120,000 2,376
135,956 2,376
5 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 155,965 155,965
Trade creditors 598 1,202
Amounts owed to group undertakings and undertakings in which the company has a participating interest 111,341 39,133
Taxation and social security costs - 828
Other creditors 1,000 170,355
268,904 367,483
6 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 780,217 860,194
7 Other information
RSR Pharmacare Limited is a private company limited by shares and incorporated in England. Its registered office is:
10 Eastglade
Pinner
HA5 3AN
RSR Pharmacare Limited 08639222 false 2023-09-01 2024-08-31 2024-08-31 VT Final Accounts April 2025 Mr. H. Panchmatia No description of principal activity 08639222 2022-09-01 2023-08-31 08639222 core:WithinOneYear 2023-08-31 08639222 core:AfterOneYear 2023-08-31 08639222 core:ShareCapital 2023-08-31 08639222 core:SharePremium 2023-08-31 08639222 core:RetainedEarningsAccumulatedLosses 2023-08-31 08639222 2023-09-01 2024-08-31 08639222 bus:EntityNoLongerTradingButTradedInPast 2023-09-01 2024-08-31 08639222 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 08639222 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 08639222 bus:Director40 2023-09-01 2024-08-31 08639222 1 2023-09-01 2024-08-31 08639222 2 2023-09-01 2024-08-31 08639222 countries:England 2023-09-01 2024-08-31 08639222 bus:FRS102 2023-09-01 2024-08-31 08639222 bus:FilletedAccounts 2023-09-01 2024-08-31 08639222 2024-08-31 08639222 core:WithinOneYear 2024-08-31 08639222 core:AfterOneYear 2024-08-31 08639222 core:ShareCapital 2024-08-31 08639222 core:SharePremium 2024-08-31 08639222 core:RetainedEarningsAccumulatedLosses 2024-08-31 08639222 2023-08-31 iso4217:GBP xbrli:pure